Vetter Development Service supports success of your compound

Published: 6-Feb-2014 Featured companies: Vetter Pharma International
Regulatory Research & Development

Vetter Development Service is a specialised area within Vetter


Your molecule’s future starts here.

By the time your new injectable compound enters clinical development, you have already invested years of painstaking work. Yet the next stage of growth is still unpredictable. And even the smallest details can influence your project’s timing, costs, and long-term success.

Vetter Development Service can help you navigate this critical phase with confidence. As your strategic partner, we provide a wide range of services tailored to your molecule’s technical and scientific needs. Discover how we can support your clinical trial goals – and help you build a seamless pathway to the future.

Click here to read more.

Featured companies

Vetter – Your partner in clinical and commercial manufacturing and packaging. Offering Drug Development, Fill and Finish, and CDMO services as well as Analytical Support,...
See more

You may also like

Research & Development

Globally operating CDMO committed to strengthening Germany as a research and production location

Read more
Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)

Trending Articles

  1. PolTREG's Treg cell therapy exhibits long-term clinical remission in type 1 diabetes patients The clinical-stage biotech's lead candidate, PTG-007, has demonstrated its ability to induce clinical remission in T1D patients for up to 12 years
  2. Vilnius University awarded €1.5m to discover the potential of jumbo phages in biotechnology The institution will look into the genetics of bacteria-infecting viruses, and how the biotech industry can learn from them when developing therapeutics
  3. Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
  4. iotaSciences launches new single-cell cloning platform XT to increase throughput and speed The platform includes novel AI-powered single-cell verification and monoclonality reporting for gene therapy
  5. PacBio launches Vega system, a compact long-read sequencing platform New benchtop sequencer brings HiFi technology to researchers at $169,000

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Research & Development

Globally operating CDMO committed to strengthening Germany as a research and production location

Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Regulatory

Vetter Development Service Rankweil successfully completes reinspection

Vetter’s European clinical site receives permanent Manufacturer’s Authorisation
Manufacturing

Gold status for Vetter: named best managed company for the fourth time

As one of the leading companies in the highly regulated and energy-intensive biopharma industry, Vetter has already been CO2-neutral worldwide since 2021
Research & Development

Vetter expands clinical development and manufacturing capabilities

The further expansion of the site will make it possible to more than double the production volume by the end of the year
Manufacturing

Vetter achieves six wins in CDMO leadership awards

In addition, the company was awarded "Champion Status" for quality, expertise and compatibility
Drug Delivery

Vetter’s clinical facility in full swing

The success was demonstrated with five client products now on the market
Regulatory

Vetter participates in third University of St. Gallen benchmarking

Previously, the company’s microbiology and chemical analysis departments received positive ratings in their benchmarkings
Subscribe now